Altria Group, Inc. (MO) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Consumer Defensive name (Tobacco) last closed at $65.19. The rating moved from Oversold to Neutral on August 19, 2026.

• Public ratingNeutral (as of August 19, 2026)
• Last close$65.19
• Last changeMoved from Oversold to Neutral on August 19, 2026
• SectorConsumer Defensive
• IndustryTobacco

AI analysis

Altria combines predictable cash generation and a high dividend yield with limited near-term organic growth; pricing power and product diversification partially offset steady volume declines. Key catalysts include uptake of oral nicotine products and continued disciplined capital returns, while regulatory, litigation and secular decline risks remain the primary constraints on upside. Near-term market tone (mild risk-on ahead of inflation prints) could modestly influence the share price, but fundamental drivers are company-specific: cash flow resilience versus regulatory and execution uncertainties.

Key factors

• Stable free cash flow and historically generous dividend yield supporting income-focused investor demand
• Strong pricing power in combustible tobacco has partially offset steady declines in cigarette volumes
• Diversification into reduced‑risk and oral nicotine products provides medium-term growth optionality
• Conservative capital allocation (dividends + buybacks) supports EPS stability and shareholder returns
• Defensive sector characteristics that can outperform in risk-off periods, but underperform in risk‑on rallies
• Balance sheet generally adequate for current payout profile but sensitive to large litigation or regulatory fines

Risks

• Ongoing regulatory and legal risk (flavor bans, higher excise taxes, litigation) that could materially compress volumes or increase costs
• Long-term secular decline in cigarette consumption that may outpace ability to replace volumes with alternatives
• Execution risk in new product categories (vapes, heated tobacco, nicotine pouches) and potential regulatory hurdles
• Reputational and litigation exposure from past investments or product controversies that can lead to write‑downs
• Interest-rate and macro sensitivity impacting discount rates for cash flows and investor appetite for high-yield names
• Concentration risk around core combustible business and potential volatility from material M&A or asset‑sale decisions

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.